The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by NASDAQ OMX. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Heads up on IBB! This is some pretty damn important support here. As a previous high flying sector, seeing this fail here could be a sign of further weakness in the broad markets, or at least thinner markets heading higher which is bad.
Biotechnology stocks continue to take a beating with the $IBB trading at $281.63, -4.60 (-1.61%). Mylan NV (NASDAQ:MYL) raising the price 400% of life saving Epipen has renewed the political firestorm. Candidate Hillary Clinton is using this price gouging as a talking point, claiming she will cap and penalize biotech companies that raise prices rediculous amounts. Investors are selling biotech on the uncertainty of future profits. While biotech falls, I am scoping out a level to buy as a swing trade. As a advanced swing trader, it is key to isolate a stock chart level that has multiple reasons for you to buy the stock, or in this case the ETF IBB. 1. The daily chart of IBB has the 50 moving average at $277.00. 2. There is a key gap fill and major support at $276.50. 3. There is a 38.2% Fibonacci retrace level at $277.00 Three key levels in one spot give extremely good odds of a bounce. I am looking to buy the second IBB breaks a few pennies below $277.00. By Pro-Trader Jenny Rebekka
It is pretty crazy to think a stock chart can predict an event but the biotechnology ETF $IBB looks to have done just that. Yesterday, the ETF that tracks biotechnology and pharma stocks slammed into a trend line that is found by connecting the recent highs (see the chart below). Any technical trader will tell you that a sharp pull back should occur. Out walked Donald Trump today to give his press conference. One of the first things he did is trash biotech/pharma stocks over drug prices. The $IBB (biotech ETF) collapsed. The stock chart here predicted the price action perfectly. However, most investors ignore the stock charts and trade off of CNBC and other media hype. Start watching the stock charts and become a better trader.
This drop is a reflection of the lightning speed of over-reaction in an emotion driven market. IBB rebound in the morning.
$IBB nice run today but watch out for the 1/10 distro bar between 278-286. Might need some time to work it off
Jumped in this morning but seemed premature so I dumped my position for a scratch: Still have my eye on it for the long term though
Technical bounce off the $100-101 level, it's now a 4x bottom But it broke below the 200 ma, and looks to be in trouble.
